Neumeyer JL - Search Results

1

Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

Zhang A, Neumeyer JL, Baldessarini RJ. Zhang A, et al. Among authors: neumeyer jl. Chem Rev. 2007 Jan;107(1):274-302. doi: 10.1021/cr050263h. Chem Rev. 2007. PMID: 17212477 Review. No abstract available.

2

Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders.

Ye N, Neumeyer JL, Baldessarini RJ, Zhen X, Zhang A. Ye N, et al. Among authors: neumeyer jl. Chem Rev. 2013 May 8;113(5):PR123-78. doi: 10.1021/cr300113a. Epub 2013 Mar 7. Chem Rev. 2013. PMID: 23464812 Review. No abstract available.

3

Synthesis and amine transporter affinities of novel phenyltropane derivatives as potential positron emission tomography (PET) imaging agents.

Peng X, Zhang A, Kula NS, Baldessarini RJ, Neumeyer JL. Peng X, et al. Among authors: neumeyer jl. Bioorg Med Chem Lett. 2004 Nov 15;14(22):5635-9. doi: 10.1016/j.bmcl.2004.08.049. Bioorg Med Chem Lett. 2004. PMID: 15482938

4

Synthesis of 2-fluoro-11-hydroxy-N-propylnoraporphine: a potential dopamine D2 agonist.

Zhang A, Csutoras C, Zong R, Neumeyer JL. Zhang A, et al. Among authors: neumeyer jl. Org Lett. 2005 Jul 21;7(15):3239-42. doi: 10.1021/ol051010d. Org Lett. 2005. PMID: 16018630

5

Synthesis and dopamine receptor binding of sulfur-containing aporphines.

Tóth M, Berényi S, Csutorás C, Kula NS, Zhang K, Baldessarini RJ, Neumeyer JL. Tóth M, et al. Among authors: neumeyer jl. Bioorg Med Chem. 2006 Mar 15;14(6):1918-23. doi: 10.1016/j.bmc.2005.10.049. Epub 2005 Nov 15. Bioorg Med Chem. 2006. PMID: 16290940

6

Advances in development of dopaminergic aporphinoids.

Zhang A, Zhang Y, Branfman AR, Baldessarini RJ, Neumeyer JL. Zhang A, et al. Among authors: neumeyer jl. J Med Chem. 2007 Jan 25;50(2):171-81. doi: 10.1021/jm060959i. J Med Chem. 2007. PMID: 17228858 Review. No abstract available.

7

R(-)2-fluoro-N-n-propylnorapomorphine: a very potent and D2-selective dopamine agonist.

Baldessarini RJ, Kula NS, Gao Y, Campbell A, Neumeyer JL. Baldessarini RJ, et al. Among authors: neumeyer jl. Neuropharmacology. 1991 Jan;30(1):97-9. doi: 10.1016/0028-3908(91)90049-h. Neuropharmacology. 1991. PMID: 1675452

8

Synthesis and structural requirements of N-substituted norapomorphines for affinity and activity at dopamine D-1, D-2, and agonist receptor sites in rat brain.

Gao YG, Ram VJ, Campbell A, Kula NS, Baldessarini RJ, Neumeyer JL. Gao YG, et al. Among authors: neumeyer jl. J Med Chem. 1990 Jan;33(1):39-44. doi: 10.1021/jm00163a007. J Med Chem. 1990. PMID: 2136919

9

Microwave-promoted Pd-catalyzed cyanation of aryl triflates: a fast and versatile access to 3-cyano-3-desoxy-10-ketomorphinans.

Zhang A, Neumeyer JL. Zhang A, et al. Among authors: neumeyer jl. Org Lett. 2003 Jan 23;5(2):201-3. doi: 10.1021/ol027256p. Org Lett. 2003. PMID: 12529140

10

Synthesis and pharmacological evaluation of 6,7-indolo/thiazolo-morphinans--further SAR of levorphanol.

Zhang A, Li F, Ding C, Yao Q, Knapp BI, Bidlack JM, Neumeyer JL. Zhang A, et al. Among authors: neumeyer jl. J Med Chem. 2007 May 31;50(11):2747-51. doi: 10.1021/jm0701674. Epub 2007 May 9. J Med Chem. 2007. PMID: 17488103

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

215 results

Search Page

Filters